Correlation of Adventitial Vasa Vasorum with Intracranial Atherosclerosis: A Postmortem Study

Article information

J Stroke. 2018;20(3):342-349
Publication date (electronic) : 2018 September 30
doi :
aDepartment of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
bThe Russell H. Morgan Department of Radiology and Radiological Sciences, The Johns Hopkins Hospital, Baltimore, MD, USA
cDepartment of Pathology, China-Japan Union Hospital of Jilin University, Jilin, China
dCenter for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin, China
eDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong
Correspondence: Xiang Yan Chen Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Tel: +852-34008891 Fax: +852-23624365 E-mail:
Co-correspondence: Thomas Wai Hong Leung Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong Tel: +852-26352130 Fax: +852-26493761 E-mail:
Received 2018 April 30; Revised 2018 August 6; Accepted 2018 August 7.


Background and Purpose

Vasa vasorum (VV) have been believed to be rare or non-existent in small-caliber intracranial arteries. In a series of human cerebral artery specimens, we identified and examined the distribution of VV in association with co-existing intracranial atherosclerosis.


We obtained cerebral artery specimens from 32 consecutive autopsies of subjects aged 45 years or above. We scrutinized middle cerebral artery (MCA), vertebral artery (VA), and basilar artery (BA) for the presence of adventitial VV. We described the distribution of VV, and the characteristics of co-existing atherosclerotic lesions.


Among 157 intracranial arteries, adventitial VV were present in 74 of the 157 specimens (47%), involving MCA (n=13, 18%), BA (n=14, 19%), and VA (n=47, 64%). Although qualitatively these 74 adventitial VV distributed similarly in arteries with or without atherosclerotic lesions (disease-free arteries n=4/8; arteries of pre-atherosclerosis n=17/42; and arteries of progressive atherosclerosis n=53/107), the presence of adventitial VV in intracranial VA was associated with a heavier plaque load (1.72±1.66 mm2 vs. 0.40±0.32 mm2, P<0.001), severer luminal stenosis (25%±21% vs. 12%±9%, P=0.002), higher rate of concentric lesions (79% vs. 36%, P=0.002), and denser intraplaque calcification (44% vs. 0%, P=0.003). Histologically, intracranial VA with VV had a larger diameter (3.40±0.79 mm vs. 2.34±0.58 mm, P<0.001), thicker arterial wall (0.31±0.13 mm vs. 0.23±0.06 mm, P=0.002), and a larger intima-media (0.19±0.09 mm vs. 0.13± 0.04 mm, P=0.003) than VA without VV.


Our study demonstrated the distribution of adventitial VV within brain vasculature and association between vertebral VV and progressive atherosclerotic lesions with a heavier plaque load and denser intraplaque calcification.


Atherosclerosis is a chronic progressive disease characterized by lipid accumulation in the vascular wall and fibrous cap formation [1,2]. Intracranial atherosclerosis is a major cause of stroke and may account for 30% to 50% of ischemic events in Asians [3-5]. As a critical contributor to the development of atherosclerosis, inflammation has been shown to progress inward from adventitia to intima [2,6,7].

Histologically, adventitia consists of connective tissue, fibroblasts, and vasa vasorum (VV) [1]. VV constitute a network of microvasculature and play a nutritive role with drainage capacity in the arterial vessel walls [8]. Studies have shown that VV may function as a conduit for transporting inflammatory mediators [9-11], and therefore, may play a passive role in the pathogenesis of atherosclerosis, aneurysm, vasculitis, and graft vascular disease [11,12]. Adventitial VV in coronary and carotid arteries may contribute to the vulnerability of atherosclerotic plaques [10]. However, the ability of cerebral arteries to receive nourishment from surrounding cerebrospinal fluid may help explain the relative absence of intracranial VV from early life [13].

Previous autopsy studies reported intracranial VV by immunohistochemical examination [14,15]. Nevertheless, compared with the extracranial VV, knowledge on the histopathology of intracranial VV is scarce, partly owing to the relative inaccessibility of intracranial arteries. Understanding adventitial VV development in cerebral arteries and its relationship to atherosclerosis may shed light on mechanisms of ischemic stroke due to presumed intracranial atherosclerosis. Based on a series of human cerebral artery specimens in our biobank [16-19], we investigated the distribution of adventitial VV in intracranial large arteries and studied its potential association with co-existing atherosclerosis.



We selected 32 Chinese autopsies from December 2003 to June 2005 in the Prince of Wales Hospital, Hong Kong [16]. Clinical Research Ethics Committee of the Chinese University of Hong Kong approved the study. Pathologists who performed the autopsy were blinded to the study purpose. We obtained subject demographics and clinical data from hospital electronic records. The causes of death were cardiovascular disease (n=13, 41%, e.g., coronary artery disease, hypertensive heart disease, ischemic stroke, or brain hemorrhage); infection or sepsis (n=3, 9%); other natural causes (n=13, 41%, e.g., hepatitis); or unnatural causes (n=3, 9%, e.g., suicides or accidents).


We sampled 157 intracranial arteries from 32 autopsy cases, including M1 segments of bilateral middle cerebral arteries (MCA, n=64), basilar artery (BA, n=32), and V4 segments of bilateral vertebral arteries (VA, n=61; three individuals had a single VA). We obtained and labeled each 4 mm cross-sectional cut of cerebral arteries from formalin-fixed brains. Each segment was decalcified overnight in 10% formic acid, followed by perfusion fixation in fresh 30% formaldehyde. After embedding in paraffin, five-micron-thick cuts were obtained from each arterial block for staining (one section per staining) with hematoxylin and eosin (H&E) for structural evaluation. We used Victoria Blue staining to mark the internal elastic lamina (IEL) for morphological measurements. For immunohistochemistry, we used Abcam (Cambridge, UK) antigen retrieval solution to retrieve antigen. The sections were then incubated with 3% hydrogen peroxide for 15 minutes and bovine serum albumin for 1 hour and stained with the following primary antibodies: von Willebrand factor (vWF) (1:200, Agilent Dako, Santa Clara, CA, USA) and CD68 (1:200, Sigma, St. Louis, MO, USA).

We photographed the slides with a Leica DC 200 digital microscope (Leica, Witzlar, Germany). Two pathologists (H.L.Z. and C.B.N.) blinded to clinical data examined all histological sections to grade atherosclerotic lesions and to record the plaque features. Another two investigators (L.Z. and W.J.Y.) independently located and described the distribution of VV: adventitial VV were identified by H&E staining (Figure 1A-C and Supplementary Figure 1), as well as immunostaining that outlined the diffuse perivascular deposits of vWF surrounding a microvessel (Figure 1D). Based on the revised American Heart Association (AHA) criteria [20], we classified the arteries into three groups: (1) disease-free, with normal intima; (2) pre-atherosclerotic lesions showing intimal thickening or intimal xanthoma; and (3) progressive atherosclerotic lesions showing pathologic intimal thickening, fibrous cap atheroma or fibrocalcific plaque. Concentric lesions were plaques involving the entire circumference of the ILE, whereas eccentric plaques had intervening diseasefree wall [21]. We recorded the characteristics of a complicated plaque, if any, including intraplaque hemorrhage (Figure 2A), calcification (Figure 2B), macrophage infiltration (Figure 2C), and thrombus (Figure 2D).

Figure 1.

Vasa vasorum in adventitia of cerebral arteries (arrows). (A) Middle cerebral artery (H&E stain). (B) Basilar artery (H&E stain). (C) Vertebral artery (H&E stain). (D) Immunochemical staining for von Willebrand factor revealed multiple vasa vasorum (short arrows).

Figure 2.

Plaque composition in intracranial arteries. (A) Intraplaque hemorrhage (asterisks) (H&E stain). (B) Calcification (arrowheads) (H&E stain). (C) Macrophage infiltration (long arrows) (CD68 antibodies staining). (D) Lumen thrombi (asterisk) (H&E stain).

Image analysis

We used Image-Pro Plus software to assess arterial structure. Based on the method described by Gutierrez et al. [22], we measured arterial diameter, wall thickness, intima-media thickness, adventitia thickness, area of atherosclerotic plaque (plaque load), and percentage of luminal narrowing (area stenosis). We traced the border of external adventitia, media, IEL and plaque manually and calculated the length and area with software. After outlining the perimeters of different layers as Pouter, Pmedia, and PIEL, we calculated Rartery, Rmedia, and RIEL by radius = perimeter / 2π. The thicknesses (Th) of adventitia and intima-media were calculated as follows: Thadventitia = Rartery – Rmedia, Thintima-media = Rmedia – RIEL. The wall thickness was the sum of Thadventitia and Thintima-media. We derived the luminal area by AIEL= PIEL2 / 4π, and the area stenosis by (plaque load / AIEL) × 100.

Statistical analysis

We analyzed data using SPSS version 20.0 software package (IBM Co., Armonk, NY, USA). For comparisons among different cerebral arteries for the 32 subjects, we used mean values of the MCAs and VAs for a given autopsy case and comparisons were made using chi-square test for categorical data and paired t-test for continuous variables. Comparisons between arteries with and without adventitial VV were made by independent sample t-test for continuous variables and chisquare test for categorical variables. Results are presented as mean±SD. We considered P<0.05 as statistically significant. For multiple testing, a significance level was considered as 0.016 (P=0.05/3) by Bonferroni correction.


Sample description

We selected all 32 Chinese adult autopsies aged 45 years or above from December 2003 to June 2005. Median age was 71 years (range, 45 to 97). Twenty-three (72%) were male. For cardiovascular risk factors, smoking was found in nine cases (28%), hypertension in nine (28%), and diabetes mellitus in six (19%). For the history of clinical cardiovascular events, nine had ischemic heart disease (28%), 14 had ischemic stroke (44%), and two had hemorrhagic stroke (6%). Table 1 summarizes the demographics and risk factors of the included cases.

Clinical characteristics of 32 autopsy cases

Anatomy and distribution of adventitial VV

We scrutinized 157 intracranial arteries: 64 MCAs, 32 BAs, and 61 VAs. Table 2 shows comparison of histologic features among different intracranial arteries. MCA had a thinner arterial wall than VA (0.22±0.08 mm vs. 0.29±0.10 mm, P<0.016). VA had a significantly thicker adventitia (0.11±0.05 mm, P<0.016) than MCA or BA. BA had a larger artery diameter (3.41±0.66 mm vs. 3.08±0.57 mm, P<0.016) and a thicker intima-media (0.19±0.07 mm vs. 0.16±0.07 mm, P<0.016) than MCA. The area stenosis (%) was greatest in MCA compared with BA or VA (31%±20% vs. 20%±19% or 31%±20% vs. 22%±15%; P<0.01, respectively). Adventitial VV were most prevalent in VA (47/61) compared with MCA (13/64) or BA (14/32) (77% vs. 20% or 77% vs. 44%; P<0.016, respectively).

Histologic features of different intracranial arteries

Association between VV and phenotypes of atherosclerosis

Based on the revised AHA criteria, eight arteries (5%) were disease-free with normal intima, 42 (27%) had pre-atherosclerotic lesions, and 107 (68%) had progressive atherosclerotic lesions. Among all 157 arterial distributed segments, we identified adventitial VV in 74 specimens (47%): 13 MCAs (18%), 14 BAs (19%), and 47 VAs (64%). In terms of co-existing atherosclerosis, these 74 adventitial VV were present in four disease-free segments (5%), in 17 segments with pre-atherosclerotic lesions (23%), and in 53 segments with progressive atherosclerotic lesions (72%). In MCA and BA, the prevalence of atherosclerotic lesions did not significantly differ between arteries with adventitial VV and those without. However, in VA, arteries with adventitial VV were likely to have more co-existing progressive atherosclerotic lesions compared to arteries without adventitial VV (68% vs. 29%, P<0.05) (Table 3).

Adventitial vasa vasorum and stages of atherosclerosis

Association between adventitial VV and atherosclerotic surrogates in VA

Table 4 compares the anatomy and atherosclerotic features in VA with and without VV. The VA with adventitial VV had a larger diameter (3.40±0.79 mm vs. 2.34±0.58 mm, P<0.001), a thicker arterial wall (0.31±0.13 mm vs. 0.23±0.06 mm, P=0.002), and a thicker intima-media (0.19±0.09 mm vs. 0.13±0.04 mm, P=0.003) than VA without VV. The adventitial VV in V4 segments was associated with a heavier plaque load (1.72±1.66 mm2 vs. 0.40±0.32 mm2, P<0.001), severer area stenosis (25%±21% vs. 12%±9%, P=0.002), higher rate of concentric lesions (79% vs. 36%, P=0.002), and denser intraplaque calcification (43% vs. 0%, P=0.003).

Adventitial vasa vasorum and atherosclerosis in vertebral artery


In this autopsy study, we found adventitial VV in nearly half (74/157, 47%) of all intracranial arterial segments, predominantly in V4 segments of VA (64%), followed by BA (19%) and MCA (18%). Overall, adventitial VV were present in disease-free arteries (4/8, 50%) as well as in arteries with pre-atherosclerotic (17/42, 40%) or progressive atherosclerotic lesions (53/107, 50%). In VA, adventitial VV were associated with concentric steno-occlusive atherosclerotic lesions and denser intraplaque calcification.

VV are composed of artery, capillary, and vein that deliver oxygen and nutrition to and eliminate metabolic wastes from the vessel wall [23,24]. In contrast to the high prevalence of VV in extracranial arteries, the existence of VV in human intracranial arteries had been a debate due to paucity of cerebral specimens. In 1980s, although Zervas et al. [25] and Clower et al. [26] reported no VV in cerebral arteries in animal studies, VV were revealed in adventitia of internal carotid artery (ICA), anterior cerebral artery and MCA of five humans, suggesting that VV might be species-specific [14]. In a larger autopsy series of 15 cases aged 5 days to 86 years, Aydin [15] subsequently revealed the presence of VV in proximal intracranial segments of ICA and VA but not in BA or MCA. However, in the current study of a larger sample size, we noted that VV were frequently found in the vertebral-basilar circulation (80% in V4 segments of VA and 44% of BA), but much less in MCA (only 20%).

In our study, the adventitia of VA was significantly thicker than that of MCA and BA, and thus, the higher prevalence of VV in VA might correspond to a higher metabolic demand in a thicker vessel wall where diffusion from parent arterial lumen or CSF for nutrition or oxygen might be insufficient. A previous study reported that the extent and distribution of VV depended on the medial thickness [27]. In fact, arterial wall and intima-media layers in VA with adventitial VV were found to be thicker than those without. Our findings along with literature [14,15] suggest that adventitial VV might exist more frequently in the proximal parts of the intracranial arteries such as VA than in arteries located more distally. As a natural extension of extracranial arteries, VA is likely a transition zone that possesses certain features different from the true intracranial arteries such as MCA and BA.

Previous studies suggested that VV were extremely rare in cerebral arteries and might develop only in pathological conditions [28]. Our study findings do not substantiate this theory. On the contrary, adventitial VV were present in four disease-free arteries from two autopsies devoid of any vasculopathy. Nevertheless, while this finding might support the physiologic existence of VV in cerebral arteries, it remains unclear whether VV could trigger and exacerbate the development and progression of atherosclerosis.

In 1984, Barger et al. [29] hypothesized that VV could be involved in the process of atherosclerosis. Studies in both human autopsy [30] and animal models [31] found higher density of VV in unstable atherosclerotic lesions. In a coronary artery disease model, VV may trigger the initial stage of atherosclerosis [32]. In our study, a higher prevalence of progressive atherosclerotic lesions in V4 segments, with heavier plaque load and severer luminal stenosis were found in conjunction with adventitial VV. We postulate that adventitial neovascular network might act as conduits transporting inflammatory cells and mediators into the plaque, exacerbating the pathologic process of atherosclerosis [7,23]. In this current study, we found that cerebral arteries with VV were more likely to have atherosclerotic plaques with more hemorrhage. Immature microvessels could act as sites of inflammatory cell infiltration and intraplaque hemorrhage owing to the weak integrity of such vessels [33,34]. Studies in coronary artery and carotid showed that intraplaque hemorrhage is not only a common feature in advanced atherosclerotic plaques [35], but also plays an important role in plaque destabilization which ultimately may lead to clinical ischemic events [12,36-38]. In cerebral arteries, our previous findings demonstrated that in addition to the luminal stenosis, plaque components such as lipid and intraplaque hemorrhage may be responsible for the brain infarct [16]. Therefore, adventitial VV may play a nutritive role in the progression of intracranial atherosclerosis and might be considered as a marker of complicated plaques. However, whether adventitial VV in intracranial arteries play a causative role in brain infarction has not been well established yet.

The interpretation of our findings would be limited by the selection bias inherent to a retrospective post-mortem study. The heterogeneity of the enrolled autopsy cases could be a major source of confounder and extrapolation to the general population should be treated with caution. Considering the nature of a post-mortem study, we could not provide causal relationship between presence of VV and progression of atherosclerosis within the intracranial vascular beds. Besides, we did not analyze the association between the magnitude of adventitia VV and atherosclerosis in this study. Moreover, although our study has a relatively larger sample size compared with previous studies, the number was still insufficient to allow subgroup analysis to analyze adventitial VV in relation to various stages of atherosclerosis and to adequately adjust covariates. Future investigation may shed light on whether and how adventitial VV may impact on the evolution of atherosclerosis.


In conclusion, our investigation shows high prevalence of adventitial VV in intracranial arterial segments of VAs. In VAs, we observed an association between VV and progressive atherosclerotic lesions with a heavier plaque load and denser intraplaque calcification.

Supplementary materials

Supplementary materials related to this article can be found online at

Supplementary Figure 1.

(A, B) Vasa vasorum (triangles) of intracranial vertebral artery. These were cross-sections of two vertebral arteries showing vasa vasorum in close anatomic relation with atherosclerotic plaques (H&E stain, ×1.6).



The authors have no financial conflicts of interest.


The study was supported by grants from the National Natural Science Foundation of China (Project No. 81371297), the General Research Fund from Research Grants Council of Hong Kong (GRF, Project No. 14112916) and the Health and Medical Research Fund of Hong Kong (HMRF, Project No. 04152586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Lusis AJ. Atherosclerosis. Nature 2000;407:233–241.
2. Lu H, Daugherty A. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol 2015;26:152–153.
3. Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998;50:812–813.
4. Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000;31:2641–2647.
5. Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study. Stroke 2014;45:663–669.
6. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868–874.
7. Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation. Cardiovasc Res 2007;75:640–648.
8. Kohnken R, Scansen BA, Premanandan C. Vasa vasorum arteriopathy: relationship with systemic arterial hypertension and other vascular lesions in cats. Vet Pathol 2017;54:475–483.
9. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A 2003;100:4736–4741.
10. Gossl M, Versari D, Mannheim D, Ritman EL, Lerman LO, Lerman A. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia: implications for vulnerable plaque-development. Atherosclerosis 2007;192:246–252.
11. Herrmann J, Lerman LO, Rodriguez-Porcel M, Holmes DR Jr, Richardson DM, Ritman EL, et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 2001;51:762–766.
12. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316–2325.
13. Portanova A, Hakakian N, Mikulis DJ, Virmani R, Abdalla WM, Wasserman BA. Intracranial vasa vasorum: insights and implications for imaging. Radiology 2013;267:667–679.
14. Connolly ES Jr, Huang J, Goldman JE, Holtzman RN. Immunohistochemical detection of intracranial vasa vasorum: a human autopsy study. Neurosurgery 1996;38:789–793.
15. Aydin F. Do human intracranial arteries lack vasa vasorum? A comparative immunohistochemical study of intracranial and systemic arteries. Acta Neuropathol 1998;96:22–28.
16. Chen XY, Wong KS, Lam WW, Zhao HL, Ng HK. Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 2008;25:74–80.
17. Yang WJ, Chen XY, Zhao HL, Niu CB, Zhang B, Xu Y, et al. Postmortem study of validation of low signal on fat-suppressed T1-weighted magnetic resonance imaging as marker of lipid core in middle cerebral artery atherosclerosis. Stroke 2016;47:2299–2304.
18. Yang WJ, Chen XY, Zhao HL, Niu CB, Xu Y, Wong KS, et al. In vitro assessment of histology verified intracranial atherosclerotic disease by 1.5T magnetic resonance imaging: concentric or eccentric? Stroke 2016;47:527–530.
19. Yang WJ, Fisher M, Zheng L, Niu CB, Paganini-Hill A, Zhao HL, et al. Histological characteristics of intracranial atherosclerosis in a Chinese population: a postmortem study. Front Neurol 2017;8:488.
20. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262–1275.
21. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002;105:939–943.
22. Gutierrez J, Goldman J, Honig LS, Elkind MS, Morgello S, Marshall RS. Determinants of cerebrovascular remodeling: do large brain arteries accommodate stenosis? Atherosclerosis 2014;235:371–379.
23. Ritman EL, Lerman A. The dynamic vasa vasorum. Cardiovasc Res 2007;75:649–658.
24. Tsikaras DP, Natsis K, Hytiroglou P, Lazos L, Gigis P. Microanatomy of the vasa vasorum of the human thoracic aorta: a study utilizing a polyester resin casting technique. Morphologie 1997;81:21–22.
25. Zervas NT, Liszczak TM, Mayberg MR, Black PM. Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum. J Neurosurg 1982;56:475–481.
26. Clower BR, Sullivan DM, Smith RR. Intracranial vessels lack vasa vasorum. J Neurosurg 1984;61:44–48.
27. Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res 1967;20:409–421.
28. Takaba M, Endo S, Kurimoto M, Kuwayama N, Nishijima M, Takaku A. Vasa vasorum of the intracranial arteries. Acta Neurochir (Wien) 1998;140:411–416.
29. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310:175–177.
30. Gossl M, Versari D, Hildebrandt HA, Bajanowski T, Sangiorgi G, Erbel R, et al. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. JACC Cardiovasc Imaging 2010;3:32–40.
31. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DR Jr, Schwartz RS, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998;101:1551–1556.
32. Choi BJ, Matsuo Y, Aoki T, Kwon TG, Prasad A, Gulati R, et al. Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis. Arterioscler Thromb Vasc Biol 2014;34:2473–2477.
33. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389–395.
34. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685–693.
35. Li X, Vink A, Niessen HW, Kers J, de Boer OJ, Ploegmakers HJ, et al. Total burden of intraplaque hemorrhage in coronary arteries relates to the use of coumarin-type anticoagulants but not platelet aggregation inhibitors. Virchows Arch 2014;465:723–729.
36. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005;111:2768–2775.
37. Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000;83:361–366.
38. Kockx MM, Cromheeke KM, Knaapen MW, Bosmans JM, De Meyer GR, Herman AG, et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:440–446.

Article information Continued

Figure 1.

Vasa vasorum in adventitia of cerebral arteries (arrows). (A) Middle cerebral artery (H&E stain). (B) Basilar artery (H&E stain). (C) Vertebral artery (H&E stain). (D) Immunochemical staining for von Willebrand factor revealed multiple vasa vasorum (short arrows).

Figure 2.

Plaque composition in intracranial arteries. (A) Intraplaque hemorrhage (asterisks) (H&E stain). (B) Calcification (arrowheads) (H&E stain). (C) Macrophage infiltration (long arrows) (CD68 antibodies staining). (D) Lumen thrombi (asterisk) (H&E stain).

Table 1.

Clinical characteristics of 32 autopsy cases

Characteristic Total
Age (yr) 71 (45–97)
Male sex 23 (72)
Smoker 9 (28)
Hypertension 9 (28)
Diabetes 6 (19)
Ischemic heart disease 9 (28)
Ischemic stroke 14 (44)
Hemorrhagic stroke 2 (6)

Values are presented as median (interquartile range) or number (%).

Table 2.

Histologic features of different intracranial arteries

Variable Middle cerebral artery* Basilar artery* Vertebral artery* P P P §
Arterial diameter (mm) 3.08±0.57 3.41±0.66 3.19±0.62 0.009 0.311 0.147
Wall thickness (mm) 0.22±0.08 0.26±0.08 0.29±0.10 0.017 0.001 0.056
Intima-media thickness (mm) 0.16±0.07 0.19±0.07 0.18±0.07 0.016 0.305 0.119
Adventitia thickness (mm) 0.06±0.03 0.06±0.02 0.11±0.05 0.217 0.001 0.001
Plaque load (mm2) 1.94±1.75 1.86±2.06 1.42±1.14 0.768 0.070 0.118
Area stenosis (%) 31±20 20±19 22±15 0.001 0.006 0.571

Values are presented as mean±SD.


In each subject, the means for middle cerebral and vertebral arteries were utilized in the analysis; Comparisons made between:

middle cerebral artery and basilar artery;

middle cerebral artery and vertebral artery; and


vertebral artery and basilar artery;

Bonferroni corrected significance level P<0.016.

Table 3.

Adventitial vasa vasorum and stages of atherosclerosis

Adventitial vasa vasorum Disease free Pre-atherosclerotic lesions Progressive atherosclerotic lesions P
Middle cerebral artery
 Present (n=13) 0 (0) 2 (15) 11 (85) 0.580
 Absent (n=51) 3 (12) 8 (16) 40 (78)
Basilar artery
 Present (n=14) 2 (14) 2 (14) 10 (71) 0.543
 Absent (n=18) 1 (6) 7 (39) 10 (56)
Vertebral artery
 Present (n=47) 2 (4) 13 (28) 32 (68) 0.016*
 Absent (n=14) 0 (0) 10 (71) 4 (29)
Total (n=157) 8 (5) 42 (27) 107 (68)

Values are presented as number (%).



Table 4.

Adventitial vasa vasorum and atherosclerosis in vertebral artery

Variable All vertebral arteries (n=61) Arteries with adventitial vasa vasorum (n=47) Arteries without adventitial vasa vasorum (n=14) P
Arterial diameter (mm) 3.19±0.62 3.40±0.79 2.34±0.58 0.001*
Wall thickness (mm) 0.29±0.10 0.31±0.13 0.23±0.06 0.002*
Intima-media thickness (mm) 0.18±0.07 0.19±0.09 0.13±0.04 0.003*
Adventitia thickness (mm) 0.11±0.05 0.12±0.07 0.09±0.04 0.175
Plaque load (mm2) 1.42±1.14 1.72±1.66 0.40±0.32 0.001*
Area stenosis (%) 22±15 25±21 12±9 0.002*
Concentric distribution 42 (69) 37 (79) 5 (36) 0.002*
Intraplaque hemorrhage 7 (12) 7 (15) 0 (0) 0.125
Thrombus 6 (10) 5 (11) 1 (7) 0.700
Macrophages 24 (39) 21 (45) 3 (21) 0.118
Calcification 20 (33) 20 (43) 0 (0) 0.003*

Values are presented as mean±SD or number (%).